CHINARES PHARMA (03320): China Resources Sanjiu Medical & Pharmaceutical Net profit attributable to shareholders for the year 2024 is approximately 3.368 billion yuan, an increase of 18.05% year-on-year.

CHINARES PHARMA (03320) announced the performance of China Resources Sanjiu Medical & Pharmaceutical in 2024, with total revenue of approximately 27.617 billion yuan, a year-on-year increase of 11.63%; the net profit attributable to shareholders of the listed company is approximately 3.368 billion yuan, a year-on-year increase of 18.05%; basic earnings per share is 2.63 yuan, and it is proposed to distribute a cash dividend of 3.20 yuan (including tax) for every 10 shares to all shareholders of China Resources Sanjiu Medical & Pharmaceutical, and to make a bonus issue of 3 shares for every 10 shares to all shareholders of China Resources Sanjiu Medical & Pharmaceutical from capital reserve.